Early Registration Savings Offer Expires In:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
September 23-26, 2024
Hynes Convention CenterBoston, USA Amir HefniCEO at Resolution TherapeuticsSpeaker
Profile
Amir is the CEO of Resolution Therapeutics, joining the company in Aug 2023 from Novartis where he was Global Head of Cell and Gene Therapy. Previously, he was a Global Asset Head in Oncology at Ipsen and spent most of his career at Bristol-Myers Squibb with roles across the US and Europe. Amir holds a BSc and PhD in Pharmacology from King’s College London and an MBA from Warwick Business School.
Agenda Sessions
Pioneering Macrophage Cell Therapy for transformative outcomes in Inflammatory Organ Disease
, 2:00pmView Session